Management of Tachycardia in Hypotensive Patients Without Sepsis

Initial Assessment and Management

In hypotensive patients with tachycardia without sepsis, norepinephrine should be used as the first-line vasopressor to restore hemodynamic stability while addressing the underlying cause, as recommended by the American College of Cardiology 1
Rapidly evaluate volume status through clinical examination and consider a passive leg raise test to assess fluid responsiveness before initiating vasopressor therapy, according to the American Heart Association 1
If the patient is fluid responsive, administer crystalloids, preferably lactated Ringer's solution, while preparing for vasopressor therapy, as suggested by the American College of Cardiology 1
Establish continuous monitoring of ECG, blood pressure, oxygen saturation, and urine output, as recommended by the Society of Critical Care Medicine 1
Assess arterial blood gases and serum lactate as markers of tissue perfusion, according to the American Thoracic Society 1

Initiate norepinephrine as the first-line vasopressor to maintain mean arterial pressure ≥65 mmHg, as recommended by the Society of Critical Care Medicine 1, 2
Avoid dopamine due to its risk of tachyarrhythmias, which could worsen the existing tachycardia, except in highly selected patients with relative bradycardia, according to the American Heart Association 2
Consider adding vasopressin (up to 0.03 U/min) if norepinephrine alone is insufficient to maintain target blood pressure, as suggested by the Society of Critical Care Medicine 2

If the tachycardia is determined to be the cause of hypotension, prepare for immediate synchronized cardioversion if the patient shows signs of hemodynamic instability, as recommended by the American Heart Association 3
Consider adenosine (6 mg IV rapid push, followed by 12 mg if needed) for regular narrow-complex tachycardias while preparing for cardioversion, according to the American College of Cardiology 3, 4
Immediate synchronized cardioversion is indicated for unstable patients with wide-complex tachycardias, as recommended by the American Heart Association 3

In patients with cardiogenic shock, consider dobutamine (2.5-10 μg/kg/min) if there is evidence of low cardiac output after stabilizing blood pressure with norepinephrine, as suggested by the American College of Cardiology 1

Continuously reassess the patient's response to treatment through clinical parameters and laboratory parameters, such as lactate, as recommended by the Society of Critical Care Medicine 1
If the patient develops signs of fluid overload, reduce fluid administration, according to the European Society of Intensive Care Medicine 5